• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
高级检索

检索历史 清除

氧化低密度脂蛋白及其受体与子痫前期发病的关系

Correlation of oxidized low-density lipoprotein and lectin-like oxidized low-density lipoprotein receptor-1 with pre-eclampsia

摘要:

目的 探讨氧化低密度脂蛋白(oxLDL)及血凝集素样氧化低密度脂蛋白受体1(LOX-1)与子痫前期发病的关系.方法 选择2007年6月至2008年1月在青岛大学医学院附属医院产科住院分娩的子痫前期孕妇73例,其中轻度子痫前期孕妇35例(轻度子痫前期组),重度子痫前期孕妇38例(重度子痫前期组).选取同期正常晚期妊娠妇女45例为对照组.采用酶联免疫吸附试验检测各组孕妇血浆中oxLDL水平;采用RT-PCR、蛋白印迹法分别检测各组孕妇胎盘组织中LOX-1 mRNA及蛋白表达水平;采用RT-PCR检测各组孕妇胎盘组织中半胱氨酸天门冬氨酸蛋白酶-3(caspase-3)mRNA表达水平.结果 (1)轻度及重度子痫前期组孕妇血浆中oxLDL水平分别为(0.42±0.11)及(0.68±0.12)mg/L,明显高于对照组的(0.35±0.14)mg/L,差异有统计学意义(P<0.01);重度子痫前期组又明显高于轻度子痫前期组(P<0.01).(2)轻度及重度子痫前期组孕妇胎盘组织中LOX-1mRNA表达水平分别为0.70±0.10及0.84±0.08,明显高于对照组的0.58±0.11,差异有统计学意义(P<0.01);重度子痫前期组又明显高于轻度子痫前期组(P<0.01).(3)轻度及重度子痫前期组孕妇胎盘组织中LOX-1蛋白表达水平分别为0.79±0.15及0.90±0.12,明显高于对照组的0.68±0.11,差异有统计学意义(P<0.01);重度子痫前期组又明显高于轻度子痫前期组(P<0.01).(4)轻度及重度子痫前期组孕妇胎盘组织中caspase-3 mRNA表达水平分别为3.82±0.18及5.39±0.14,明显高于对照组的2.19±0.20,差异有统计学意义(P<0.01);重度子痫前期组又明显高于轻度子痫前期组(P<0.01).(5)轻度及重度子痫前期组孕妇血浆中oxLDL水平与胎盘组织中LOX-1 mRNA表达水平呈正相关(r=0.93,P<0.05);胎盘组织中LOX-1 mRNA表达与胎盘组织caspase-3 mRNA表达水平呈正相关(r=0.84,P<0.05).结论 子痫前期孕妇血浆中oxLDL水平升高,并上调胎盘组织中的LOX-1表达水平,从而参与子痫前期的病理生理过程.

更多
abstracts:

Objective To investigate the role of oxidized low-density lipoprotein (oxLDL) and lectin-like oxidized low-density lipoprotein receptor-1 (LOX-I) in pre-ecalmpsia. Methods From June 2007 to January 2008,73 women with pre-eelampsia who delivered in the Department of Obstetrics, Affiliated Hospital of Qingdao University Medical College,were recruited, including 35 women with mild pre-eclampsia (MPE group) and 38 women with severe pre-eclampsia(SPE group). And 45 healthy pregnant women were taken as control group. Enzyme-linked immunosorbent assay (ELISA) was used to measure the plasma concentrations of oxLDL in these women. Semiquantitative RT-PCR and Western blot were used to investigate the expression of LOX-1 mRNA and protein in placenta. The expression of caspase-3 mRNA in placenta was determined using Semiquantitative RT-PCR. Results (1) The plasma concentrations of oxLDL in MPE group ( 0.42 ± 0.11 ) mg/L, SPE group ( 0.68 ± 0.12 ) mg/L, were significantly higher compared with control group (0.35 ± 0.14 )mg/L( P < 0.01 ) and the concentrations of oxLDL in MPE group were significantly higher compared with SPE group (P<0.01 ). (2) The expression of LOX-1 mRNA in placenta of MPE group(0.70 ±0.10) and SPE group(0.84 ±0.08) were significantly higher than that in control group(0.58 ± 0.11 ) ( P<0.01 ) and the expression of LOX-1 mRNA in MPE group was significantly higher than that of SPE group (P<0.01 ). (3) The expression of LOX-1 protein in placenta of MPE group (0.79±0.15 )and SPE group(0.90±0.12) were significantly higher compared with control group(0.68 ±0.11)( P<0.01 ), while the expression of LOX-1 protein of MPE group was significantly higher compared with SPE group (P <0.01 ). (4) The expression of caspase-3 mRNA in placenta of MPE group(3.82± 0.18) and SPE group(5.39±0.14) were significantly higher than that in control group(2.19±0.20) (P <0.01 ), and the expression of caspase-3 mRNA in MPE group was significantly higher than that of SPE group (P<0.01 ). (5) In pre-eclampsia groups, the levels of LOX-1 mRNA in placenta were positively correlated with the plasma concentrations of ox LDL ( r=0.93, P<0.05 ), and caspase-3 mRNA expression were positively correlated with the expression of LOX-1 mRNA in placenta( r=0.84, P<0.05). Conclusion Increased levels of oxLDL in plasma may induce excess expression of LOX-1 in placenta, which may be involved in the pathophysiological processes of pre-eclampsia.

More
作者: 张妍 [1] 叶元华 [1] 彭伟 [1] 詹瑛 [1]
期刊: 《中华妇产科杂志》2009年44卷2期 94-98页 MEDLINEISTICPKUCSCDCA
分类号: R71
栏目名称: 子痫前期研究
DOI: 10.3760/cma.j.issn.0529-567x.2009.02.005
发布时间: 2009-04-03
  • 浏览:358
  • 下载:148

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

充值 订阅 收藏 移动端 使用
帮助